Key Insights

Highlights

Success Rate

76% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

20.0%

5 terminated out of 25 trials

Success Rate

76.2%

-10.3% vs benchmark

Late-Stage Pipeline

24%

6 trials in Phase 3/4

Results Transparency

56%

9 of 16 completed with results

Key Signals

9 with results76% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (3)
P 1 (2)
P 2 (14)
P 3 (4)
P 4 (2)

Trial Status

Completed16
Terminated5
Not Yet Recruiting1
Unknown1
Withdrawn1
Recruiting1

Trial Success Rate

76.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT06959147Phase 4Recruiting

High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia

NCT06882525Not ApplicableNot Yet Recruiting

Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia

NCT03315598Not ApplicableCompleted

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain

NCT00424372Phase 3CompletedPrimary

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

NCT00568321Phase 2CompletedPrimary

RN624 For Pain Of Post-Herpetic Neuralgia

NCT00394901Phase 3CompletedPrimary

A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia

NCT00674687Not ApplicableCompleted

A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing

NCT01678924Phase 2TerminatedPrimary

A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

NCT00160667Phase 2CompletedPrimary

A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)

NCT02484170Phase 1CompletedPrimary

Mannitol Cream for Post Herpetic Neuralgia

NCT01252160Phase 4CompletedPrimary

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

NCT00964990Phase 2Terminated

A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)

NCT00282763Phase 2TerminatedPrimary

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

NCT02426411Phase 2WithdrawnPrimary

Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN

NCT00245544Phase 2TerminatedPrimary

Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)

NCT00570310Phase 1CompletedPrimary

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

NCT00160511Phase 2CompletedPrimary

A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

NCT01129531Phase 2CompletedPrimary

A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

NCT00619476Phase 2CompletedPrimary

A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)

NCT00617461Phase 2CompletedPrimary

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Scroll to load more

Research Network

Activity Timeline